Variable | HR (IC 95%) | p-value |
Age (Years) |
|
|
<40 | Réf | 1 |
40 - 49 | 2.08 (0.22 - 19.68) | 0.521 |
50 - 59 | 2.44 (0.21 - 27.51) | 0.47 |
60 - 69 | 8.81 (0.73 - 106.20) | 0.087 |
≥70 | 19.52 (1.40 - 270.58) | 0.027* |
Distant metastasis |
|
|
M0 | Réf | 1 |
M1 | 2.37 (0.67 - 14.07) | 0.097 |
Metastasis location |
|
|
Absence | Réf | 1 |
Poumons | 0.78 (0.30 - 2.01) | 0.609 |
Poumons, Os | 1.37 (0.12 - 15.60) | 0.799 |
Vertèbre cervicale | 0.73 (0.06 - 8.22) | 0.802 |
TNM tumour stage |
|
|
Stage 1 | Réf | 1 |
Stage 2 | 2.04 (0.66 - 6.27) | 0.212 |
Stage 3 | 1.22 (0.38 - 3.91) | 0.731 |
Stage 4 | 3.32 (0.71 - 15.55) | 0.127 |
Consultation delay (Months) |
|
|
<3 | Réf | 1 |
[3 - 6] | 2.97 (0.57 - 15.26) | 0.192 |
[6 - 12] | 3.16 (0.50 - 19.71) | 0.216 |
≥12 | 2.24 (0.48 - 10.33) | 0.298 |
Limits of surgical excision |
|
|
Healthy | Réf | 1 |
Invaded | 1.11 (0.49 - 2.48) | 0.792 |
Surgery |
|
|
No sugery | Réf | 1 |
With chemotherapy | 0.42 (0.11 - 0.68) | 0.039* |
With radiotherapy | 0.45 (0.35 - 0.77) | 0.019* |
With chemotherapy + radiotherapy | 2.26 (0.73 - 7.00) | 0.156 |
Exclusive | 5.41 (0.98 - 29.92) | 0.053 |